UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat

Drug metabolism and disposition, 1999-07, Vol.27 (7), p.827

1999

Volltextzugriff (PDF)

P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells

Biochemical pharmacology, 1999-09, Vol.58 (6), p.951-957

1999

Volltextzugriff (PDF)

Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat

Pharmaceutical research, 1998-04, Vol.15 (4), p.599-605

1998

Volltextzugriff (PDF)

756P First-in-human phase I study of a novel claudin 6 (CLDN6) targeted antibody drug conjugate (ADC) TORL-1-23

Annals of oncology, 2023-10, Vol.34, p.S517-S517

2023

Volltextzugriff (PDF)

Increased brain P-glycoprotein in morphine tolerant rats

Life sciences (1973), 1999-12, Vol.66 (4), p.PL47-PL51

1999

Volltextzugriff (PDF)

Archer: Dacomitinib (D; PF-00299804) Versus Erlotinib (E) for Advanced (ADV) NSCLC; A Randomized Double-Blind Phase III Study

Annals of oncology, 2012-10, Vol.23, p.xi22-xi23

2012

Volltextzugriff (PDF)

Critical Management Studies at Work: Negotiating Tensions between Theory and Practice

1, 2009

Volltextzugriff (PDF)

PII-70A population pharmacokinetic analysis of a HER2 tyrosine kinase inhibitor CP-724714 in patients with advanced malignant HER2 positive solid tumors

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P54-P54

2006

Volltextzugriff (PDF)

PII-70

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P54-P54

2006

Volltextzugriff (PDF)

A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer

Seminars in oncology, 1995-10, Vol.22 (5), p.80-85

1995

Volltextzugriff (PDF)

Phase I trial of a 96 h paclitaxel infusion with filgrastim support in refractory solid tumor patients

Anti-cancer drugs, 1998-08, Vol.9 (7), p.611-619

1998

Volltextzugriff (PDF)

First-in-human study of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-00299804, a small molecule irreversible panHER inhibitor in patients with advanced cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.3599-3599

2007

Volltextzugriff (PDF)

PI-13Pharmacokinetics and pharmacodynamics of a HER2 tyrosine kinase inhibitor CP-724714 in patients with advanced malignant HER2 positive solid tumors

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P10-P10

2006

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine S-1 on a Once-Daily-for-28-Day Schedule in Patients with Advanced Malignancies

Clinical cancer research, 2004-08, Vol.10 (15), p.4913-4921

2004

Volltextzugriff (PDF)

PI-13

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P10-P10

2006

Volltextzugriff (PDF)

Evaluation of a novel RNA biomarker of CDK2 inhibition in phase 1 clinical trials with BMS-387032

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2031-2031

2004

Volltextzugriff (PDF)

PET as a biomarker of the antitumor effects of the CDK2 inhibitor BMS-387032

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2032-2032

2004

Volltextzugriff (PDF)

PET as a biomarker of the antitumor effects of the CDK2 inhibitor BMS-387032

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2032-2032

2004

Volltextzugriff (PDF)

Evaluation of a novel RNA biomarker of CDK2 inhibition in phase 1 clinical trials with BMS-387032

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2031-2031

2004

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Once Daily Oral Administration of S-1 in Patients with Advanced Cancer

Clinical cancer research, 2002-07, Vol.8 (7), p.2116-2122

2002

Volltextzugriff (PDF)

Increased brain P-glycoprotein in morphine tolerant rats

Life sciences (1973), 2000-01, Vol.66 (4), p.PL47-PL51

2000

Volltextzugriff (PDF)

Introduction: Intersections of Critical Management Research and Practice: A Multi-Domain Perspective

Critical Management Studies at Work, 2009

2009

Volltextzugriff (PDF)

Practical Pushing: Creating Discursive Space in Organizational Narratives

Critical Management Studies at Work, 2009

2009

Volltextzugriff (PDF)

Journeys into Critical Thinking: Intersecting Foucault into the Organizational Practice Debate

Critical Management Studies at Work, 2009

2009

Volltextzugriff (PDF)

The Phantom Menace: Conducting Practitioner-Informed Research Without Losing Academic Liberties

Critical Management Studies at Work, 2009

2009

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Englisch
(77)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Management & Management Techniques
(26)
Management: Leadership & Motivation
(26)
Science & Technology
(22)
Critical Management Studies
(21)
International Business
(21)
Life Sciences & Biomedicine
(21)
Organisation Studies
(21)
Humans
(17)
Male
(15)
Organizational Behavior, Transaction Costs, Property Rights
(15)
Adult
(14)
Biological And Medical Sciences
(14)
Business Administration: General
(14)
Medical Sciences
(14)
Female
(13)
Oncology
(13)
Pharmacology. Drug Treatments
(13)
Aged
(12)
Middle Aged
(12)
Pharmacology & Pharmacy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat

P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells

Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat

756P First-in-human phase I study of a novel claudin 6 (CLDN6) targeted antibody drug conjugate (ADC) TORL-1-23

Increased brain P-glycoprotein in morphine tolerant rats

Archer: Dacomitinib (D; PF-00299804) Versus Erlotinib (E) for Advanced (ADV) NSCLC; A Randomized Double-Blind Phase III Study

Critical Management Studies at Work: Negotiating Tensions between Theory and Practice

PII-70A population pharmacokinetic analysis of a HER2 tyrosine kinase inhibitor CP-724714 in patients with advanced malignant HER2 positive solid tumors

PII-70

A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer

Phase I trial of a 96 h paclitaxel infusion with filgrastim support in refractory solid tumor patients

First-in-human study of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-00299804, a small molecule irreversible panHER inhibitor in patients with advanced cancer

PI-13Pharmacokinetics and pharmacodynamics of a HER2 tyrosine kinase inhibitor CP-724714 in patients with advanced malignant HER2 positive solid tumors

Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine S-1 on a Once-Daily-for-28-Day Schedule in Patients with Advanced Malignancies

PI-13

Evaluation of a novel RNA biomarker of CDK2 inhibition in phase 1 clinical trials with BMS-387032

PET as a biomarker of the antitumor effects of the CDK2 inhibitor BMS-387032

PET as a biomarker of the antitumor effects of the CDK2 inhibitor BMS-387032

Evaluation of a novel RNA biomarker of CDK2 inhibition in phase 1 clinical trials with BMS-387032

Phase I and Pharmacokinetic Study of Once Daily Oral Administration of S-1 in Patients with Advanced Cancer

Increased brain P-glycoprotein in morphine tolerant rats

Introduction: Intersections of Critical Management Research and Practice: A Multi-Domain Perspective

Practical Pushing: Creating Discursive Space in Organizational Narratives

Journeys into Critical Thinking: Intersecting Foucault into the Organizational Practice Debate

The Phantom Menace: Conducting Practitioner-Informed Research Without Losing Academic Liberties

Suchergebnisse filtern